Examkin

Question

Difficulty: HardPoint at Issue and Point of Agreement

Leona: Pharmaceutical corporations that develop commercial therapies based on biochemical compounds discovered in organisms inhabiting deep-sea hydrothermal vents in international waters should be legally mandated to pay royalties into an international ocean conservation trust. Because the genetic adaptations of organisms residing in international waters constitute a shared global commons, any commercial profit derived from those biological discoveries entails a reciprocal obligation to fund the preservation of those fragile habitats.

Marcus: Preserving marine habitats is certainly vital, and any enterprise that physically extracts biomass or causes direct ecological disruption to hydrothermal vent ecosystems should be heavily taxed. However, pharmaceutical companies synthesize these therapeutic compounds entirely in terrestrial laboratories using digitized genomic sequence data and standard chemical manufacturing. Because the production of synthetic compounds consumes no physical marine biomass, companies marketing purely synthetic derivatives have no obligation to contribute commercial profits to an ocean conservation trust.

The dialogue most strongly supports the claim that Leona and Marcus disagree over which one of the following?

  1. A
    whether enterprises that physically harvest biomass from hydrothermal vents in international waters should contribute financially to conservation efforts
  2. whether pharmaceutical companies should be required to contribute profits to a conservation trust when marketing purely synthetic compounds derived from deep-sea organismsAnswer
  3. C
    whether digitized genomic sequence data obtained from organisms in international waters should be kept confidential rather than shared with commercial enterprises
  4. D
    whether commercial biotechnology firms must forfeit all intellectual property protections for therapeutic compounds inspired by naturally occurring organisms
  5. E
    whether the successful laboratory synthesis of a chemical compound guarantees that the resulting therapy will generate commercial profits

Answer

The statement expressing whether pharmaceutical companies should be required to contribute profits to a conservation trust when marketing purely synthetic compounds derived from deep-sea organisms.
The correct answer accurately isolates the specific condition under dispute: whether the obligation to contribute profits to an ocean conservation fund applies to purely laboratory-synthesized compounds derived from deep-sea organisms. The first speaker claims that any commercial profit derived from deep-sea biological discoveries entails this obligation, whereas the second speaker argues that because synthetic production consumes no physical biomass, companies producing purely synthetic derivatives have no such obligation.

Step-by-Step Solution

1
Analyze the first speaker's argument and commit their stance to a clear proposition.
The first speaker contends that commercializing drugs based on biological discoveries from international marine commons incurs a legal duty to pay royalties into an ocean conservation trust, regardless of whether the final product is synthetic.
Establishing the precise scope of the first speaker's claim allows direct comparison with the second speaker's counterargument.
2
Analyze the second speaker's argument and identify concessions versus explicit objections.
The second speaker concedes that direct physical extraction should be taxed, but explicitly denies that companies marketing purely lab-synthesized derivatives without physical biomass consumption have any obligation to pay royalties.
Disagreements on Point at Issue questions require isolating where the two speakers take mutually contradictory stances.
3
Apply the Two-Speaker Test to evaluate candidate propositions.
On the question of whether marketing purely synthetic derivatives derived from deep-sea discoveries warrants mandatory conservation payments, the first speaker says 'yes' and the second speaker says 'no'.
A valid Point at Issue answer must produce opposing truth commitments from both speakers.

Key Concept

Identifying Points of Disagreement via the Two-Speaker Test
Rate this question

Topics

Point at Issue and Point of Agreement

More questions from this topic